Experimental studies (e.g. in vitro or in vivo models manipulating HSF1 expression or methylation under circadian rhythm challenges) are needed to confirm the exact functional roles of HSF1 and other identified candidate genes in the pathogenesis of T2DM. The gene discussed is HSF1; the disease is type 2 diabetes mellitus.